What is the Impact Factor of Advances in Rheumatology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Advances in Rheumatology is 2.80, ranking in quartile Q2 of Web of Science (SCIE).

Is Advances in Rheumatology indexed in Web of Science or Scopus?

Yes, Advances in Rheumatology is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.722 (Q2) and an H-index of 45.

Who publishes Advances in Rheumatology and what is the Article Processing Charge (APC)?

Advances in Rheumatology is published by BioMed Central. The estimated Article Processing Charge (APC) is approximately $3,105 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Advances in Rheumatology?

The official ISO-4 abbreviation of Advances in Rheumatology is "ADV RHEUMATOL" with common acronym "adrh". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #7,945Gold OA

Advances in Rheumatology

Acronym:adrh

•

Abbreviation (ISO):ADV RHEUMATOL

•

Identifier (ISSN):2523-3106(Print)

•

Publisher:BioMed Central

Official Website Submission Portal Compare

Clarivate IF (2026)

2.8↑ +0.7

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Advances in Rheumatology

WoS Q2

Annual Impact Factor Metric

Current (2026):2.8

Scopus SJR & RankScopus Q2

0.722

#7,945

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

45 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

71articles/year

100% Gold OA•86.36% Original Research

Aims & Scope

Formerly named Revista Brasileira de Reumatologia, the journal is celebrating its 60th year of publication. Advances in Rheumatology is an international, open access journal publishing pre-clinical, translational and clinical studies on all aspects of paediatric and adult rheumatic diseases, including degenerative, inflammatory and autoimmune conditions. The journal is the official publication of the Brazilian Society of Rheumatology and welcomes original research (including systematic reviews and meta-analyses), literature reviews, guidelines and letters arising from published material.

Topics Covered (Recognized by AI)

MedicineInternal MedicineBiologyPathologyImmunologyPsychologySurgeryPathology & DiseasesPsychiatryMathematicsGeneticsPhysical TherapyStatisticsChemistryRadiologyBiochemistryEndocrinologyGastroenterology

Primary Research Areas

Medicine Rheumatology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

RHEUMATOLOGY

Rank27/58

IndexSCIE

JCISCIE2026

RHEUMATOLOGY

Rank29/58

IndexSCIE

Category	Index	Rank	Quartile
RHEUMATOLOGY	JCRSCIE	27/58	Q2
RHEUMATOLOGY	JCISCIE	29/58	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

9 year

2026Latest

IF2.8

Articles / Year35

Total Citations2

2025

IF2.1

Articles / Year76

Total Citations80

2024

IF2

Articles / Year92

Total Citations468

2023

IF2.3

Articles / Year58

Total Citations422

2022

IF3.01

Articles / Year49

Total Citations441

Year	Impact Factor	Articles / Year	Total Citations
2026	2.8	35	2
2025	2.1	76	80
2024	2	92	468
2023	2.3	58	422
2022	3.01	49	441
2021	2.235	74	1,017
2020	0.854	50	977
2019	1.163	63	1,561
2018	1.35	43	1,095

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,945Scopus Q2SCImago Profile

Scopus Coverage:2018-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.722

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.62

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,105 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations505

3-Year Documents194

Citable Documents188

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate56.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

RheumatologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

3区RHEUMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Advances in Rheumatology (acronym: adrh, abbr: ADV RHEUMATOL, ISSN: 2523-3106) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in England since 2018. The periodical holds a Journal Impact Factor (JIF) of 2.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.722 (Q2), an H-index of 45.

The journal enforces rigorous peer evaluation with an annual output of approximately 71 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,105 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.